Solesence, Inc.

SLSN Consumer Defensive Household & Personal Products

Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.02 0.00 0.00%
Market cap
$70.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
1.02
Beneish M
−1.13
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
1.29 1.41 1.72 2.19 0.66 0.96 1.19 1.35 1.96 1.78
Receivables
6.84 4.87 3.47 4.73 3.94 2.93 0.97 0.83 1.12 0.43
Inventory
18.51 20.27 10.03 8.84 6.10 4.34 2.55 2.24 1.39 0.77
Total current assets
28.78 29.35 16.30 16.63 11.60 8.84 4.99 4.69 4.62 3.43
Property, Plant, Equpment (Net)
14.33 12.73 8.67 7.95 4.71 2.87 2.26 1.87 1.62 1.40
Long-term assets (Other)
0.04 0.00 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.02
Total non-current assets
21.28 20.65 16.58 16.93 16.80 4.71 4.39 1.88 1.64 1.42
Total Assets
50.06 50.00 32.88 33.56 28.39 13.54 9.37 6.57 6.27 4.84
Notes Payable
— — — — 1.35 2.66 0.72 0.83 0.30 —
Accounts Payable
4.10 9.09 6.26 6.36 3.57 2.13 1.75 1.61 1.04 0.67
Accrued Expenses
2.88 4.85 0.87 1.02 0.95 0.48 0.38 0.97 0.54 0.52
Current Part of Debt
4.77 5.00 4.81 4.28 — 0.50 0.50 — — —
Current Part of Capital Lease
— — — — 0.11 0.18 0.22 0.22 0.14 0.11
Current Revenue (Deferred)
0.93 5.57 2.35 2.17 0.78 0.41 0.48 0.01 — —
Total current liabilities
13.93 25.77 15.59 13.84 7.34 6.78 4.41 3.64 2.02 1.30
Long Term Debt (Total)
10.50 — 6.00 4.00 1.01 2.16 1.12 1.01 0.42 0.11
Non-current Revenue (Deferred)
— — — 0.02 0.66 — 0.09 0.34 0.41 0.47
Non-current Liabilities (Other)
0.19 0.25 0.24 0.23 0.22 0.21 0.21 0.20 0.18 0.18
Total non-current liabilities
18.49 9.28 15.39 14.07 13.59 4.02 3.45 1.55 1.01 0.75
Total liabilities
32.42 35.06 30.98 27.91 20.93 10.81 7.86 5.19 3.03 2.05
Additional Paid In Capital
115.57 114.67 106.07 105.23 104.42 102.12 101.89 98.80 98.56 97.36
Common Stock (Net)
0.71 0.70 0.50 0.49 0.49 0.38 0.38 0.34 0.34 0.31
Retained Earnings
(98.64) (100.43) (104.66) (100.07) (97.45) (99.77) (100.76) (97.75) (95.67) (94.88)
Common Equity (Total)
17.63 14.95 1.90 5.65 7.47 2.73 1.51 1.38 3.23 2.79
Shareholders Equity (Total)
17.63 14.95 1.90 5.65 7.47 2.73 1.51 1.38 3.23 2.79
Shareholders Equity and Liabilities (Total)
50.06 50.00 32.88 33.56 28.39 13.54 9.37 6.57 6.27 4.84
Shares (Common)
70.61 70.10 49.63 49.32 48.89 38.22 38.14 33.91 33.85 31.23
Shareholders Equity (Tangible)
17.63 14.95 1.90 5.65 7.47 2.73 1.51 1.38 3.23 2.79
Net Debt
13.98 3.59 9.09 6.10 0.35 1.70 0.42 (0.34) (1.54) (1.67)
Total Debt
15.27 5.00 10.81 8.28 1.01 2.66 1.62 1.01 0.42 0.11

Fold the line items

In millions of $ except per-share values · columns are period end dates